Research interests
Research at our department follows the drug pipeline process. The list below contains the people who specialise in each stage and substage of the drug pipeline.
Target Identification
- Human neurodegeneration: Professor Mike Dragunow
- Neural reprogramming and repair: Professor Bronwen Connor
- Molecular Basis for Disease: Dr Raewyn Poulsen
Hit Discovery
- Drug discovery: Associate Professor Jack Flanagan
Lead Generation
- Cancer drug development: Dr Steve Jamieson
- Receptors in Health and Disease: Dr Natasha Grimsey
Pre-Clinical
- Drug metabolism and toxicology: Professor Malcolm Tingle
- New therapies for brain diseases: Associate Professor Debbie Young
Clinical
- Cancer pharmacology: Professor Mark McKeage & Dr Catherine Han
- Pharmacokinetics & drug safety: Dr Jacqui Hannam, Dr Katie Burns & Professor Malcolm Tingle
- Disease progress and drug action: Professor Nick Holford